These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 39419848)

  • 1. First-in-human study of dosimetry, safety and efficacy for [
    Zhao R; Lv J; Li M; Xu S; Liang W; Lin X; Gu D; Zeng G; Jin W; Yan Q; Zhong H; Alexoff D; Ploessl K; Zhu L; Kung HF; Wang X
    Eur J Nucl Med Mol Imaging; 2024 Oct; ():. PubMed ID: 39419848
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety and Efficacy of 68 Ga- or 177 Lu-Labeled DOTA-IBA as a Novel Theranostic Radiopharmaceutical for Bone Metastases : A Phase 0/I Study.
    Qiu L; Wang Y; Liu H; Wang Q; Chen L; Liu L; Wang L; Feng Y; Chen Y
    Clin Nucl Med; 2023 Jun; 48(6):489-496. PubMed ID: 36976706
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prostate-Specific Membrane Antigen Radioligand Therapy Using
    Schuchardt C; Zhang J; Kulkarni HR; Chen X; Müller D; Baum RP
    J Nucl Med; 2022 Aug; 63(8):1199-1207. PubMed ID: 34887335
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biodistribution and dosimetry of
    Li H; Pei W; Yang X; Qu G; Hua Q; Liu L; Wang Y; Xu T; Chen Y
    EJNMMI Res; 2024 Mar; 14(1):30. PubMed ID: 38517637
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of Safety and Dosimetry of
    Fernández R; Eppard E; Lehnert W; Jiménez-Franco LD; Soza-Ried C; Ceballos M; Ribbeck J; Kluge A; Rösch F; Meckel M; Zhernosekov K; Kramer V; Amaral H
    J Nucl Med; 2021 Aug; 62(8):1126-1132. PubMed ID: 33419945
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Personalized dosimetry assessment of [
    Kazemi-Jahromi M; Yazdani E; Karamzade-Ziarati N; Asadi M; Sadeghi M; Geramifar P
    Int J Radiat Biol; 2024; 100(11):1551-1559. PubMed ID: 39302840
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biodistribution and post-therapy dosimetric analysis of [
    Khawar A; Eppard E; Roesch F; Ahmadzadehfar H; Kürpig S; Meisenheimer M; Gaertner FC; Essler M; Bundschuh RA
    EJNMMI Res; 2019 Nov; 9(1):102. PubMed ID: 31781962
    [TBL] [Abstract][Full Text] [Related]  

  • 8. First-in-human dosimetry of gastrin-releasing peptide receptor antagonist [
    Kurth J; Krause BJ; Schwarzenböck SM; Bergner C; Hakenberg OW; Heuschkel M
    Eur J Nucl Med Mol Imaging; 2020 Jan; 47(1):123-135. PubMed ID: 31482426
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative Therapeutic Efficacy of
    Sharma S; Singh B; Koul A; Mittal BR
    Front Med (Lausanne); 2017; 4():46. PubMed ID: 28507988
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of different methods for post-therapeutic dosimetry in [
    Rosar F; Schön N; Bohnenberger H; Bartholomä M; Stemler T; Maus S; Khreish F; Ezziddin S; Schaefer-Schuler A
    EJNMMI Phys; 2021 May; 8(1):40. PubMed ID: 33950333
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biodistribution, dosimetry, and temporal signal-to-noise ratio analyses of normal and cancer uptake of [
    Doot RK; Young AJ; Daube-Witherspoon ME; Alexoff D; Labban KJ; Lee H; Wu Z; Zha Z; Choi SR; Ploessl KH; Schubert EK; Lee H; Zhu L; Reddin JS; Karp JS; Kung H; Pryma DA
    Nucl Med Biol; 2020; 86-87():1-8. PubMed ID: 32361089
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A phase 1 trial to determine the maximum tolerated dose and patient-specific dosimetry of [
    Zang J; Wang G; Zhao T; Liu H; Lin X; Yang Y; Shao Z; Wang C; Chen H; Chen Y; Zhu Z; Miao W; Chen X; Zhang J
    Eur J Nucl Med Mol Imaging; 2024 Feb; 51(3):871-882. PubMed ID: 37864592
    [TBL] [Abstract][Full Text] [Related]  

  • 13. First-in-human study of
    Zang J; Fan X; Wang H; Liu Q; Wang J; Li H; Li F; Jacobson O; Niu G; Zhu Z; Chen X
    Eur J Nucl Med Mol Imaging; 2019 Jan; 46(1):148-158. PubMed ID: 30090965
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dosimetry for (177)Lu-DKFZ-PSMA-617: a new radiopharmaceutical for the treatment of metastatic prostate cancer.
    Delker A; Fendler WP; Kratochwil C; Brunegraf A; Gosewisch A; Gildehaus FJ; Tritschler S; Stief CG; Kopka K; Haberkorn U; Bartenstein P; Böning G
    Eur J Nucl Med Mol Imaging; 2016 Jan; 43(1):42-51. PubMed ID: 26318602
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prospective evaluation of organ-specific dose and lesional doses following therapeutic [177Lu]Lu-EDTMP administration in patients with multiple skeletal metastases and its correlation with clinical hematological toxicity.
    Kamaldeep ; Thapa P; Wanage G; Tervankar S; Kaisar S; Ranade R; Basu S; Das T; Banerjee S
    Nucl Med Commun; 2021 Oct; 42(10):1076-1084. PubMed ID: 34528928
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Studies on 177Lu-labeled methylene diphosphonate as potential bone-seeking radiopharmaceutical for bone pain palliation.
    Abbasi IA
    Nucl Med Biol; 2011 Apr; 38(3):417-25. PubMed ID: 21492790
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An Intrapatient Dosimetry Comparison of
    Rinscheid A; Gäble A; Wienand G; Pfob C; Dierks A; Kircher M; Trepel M; Weckermann D; Lapa C; Bundschuh RA
    J Nucl Med; 2023 Dec; 64(12):1918-1924. PubMed ID: 37770108
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 3D Monte Carlo bone marrow dosimetry for Lu-177-PSMA therapy with guidance of non-invasive 3D localization of active bone marrow via Tc-99m-anti-granulocyte antibody SPECT/CT.
    Gosewisch A; Ilhan H; Tattenberg S; Mairani A; Parodi K; Brosch J; Kaiser L; Gildehaus FJ; Todica A; Ziegler S; Bartenstein P; Böning G
    EJNMMI Res; 2019 Aug; 9(1):76. PubMed ID: 31414241
    [TBL] [Abstract][Full Text] [Related]  

  • 19. First-In-Human Results on the Biodistribution, Pharmacokinetics, and Dosimetry of [
    Ballal S; Yadav MP; Moon ES; Kramer VS; Roesch F; Kumari S; Bal C
    Pharmaceuticals (Basel); 2021 Nov; 14(12):. PubMed ID: 34959613
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of Safety, Biodistribution, and Dosimetry of a Long-Acting Radiolabeled Somatostatin Analog 177 Lu-DOTA-EB-TATE With and Without Amino Acid Infusion.
    Jiang Y; Liu Q; Wang G; Zhang J; Zhu Z; Chen X
    Clin Nucl Med; 2023 Jun; 48(6):e289-e293. PubMed ID: 37075254
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.